The delivery of drugs by inhalation is an integral component of asthma and chronic
obstructive pulmonary disease (COPD) management. However, even with effective inhaled …

Chronic obstructive pulmonary disease (COPD) continues to be associated with increased
morbidity and mortality risk in spite of updated guidelines and a better understanding of this …

Chronic obstructive pulmonary disease (COPD) represents a socio-economic burden and
requires regular and ongoing treatment. Inhalation therapy is recommended at all stages of …

Inhaled medication is the cornerstone in the treatment of patients across a spectrum of
respiratory diseases including asthma and chronic obstructive pulmonary disease. The …

Introduction: Aerosolized medications are commonly prescribed for the treatment of patients
with pulmonary diseases, and there has been an increased interest in the development of …

Inhalation therapy allows conveying drugs directly into the airways. The devices used to
administer inhaled drugs play a crucial role in the management of obstructive lung diseases …

Ideally, inhaled therapy is driven by the needs of specific disease management. Lung
biology interfaces with inhaler performance to allow optimal delivery of therapeutic agent for …

Inhaled pharmaceuticals are formulated and delivered differently according to the
therapeutic indication. However, specific device-formulation coupling is often fickle, and new …

A variety of inhaler devices are available for delivering treatments to patients with chronic
obstructive pulmonary disease, and new inhalers are currently being developed. Each type …

Introduction: There is increasing interest in the pulmonary route for both local and
systemically acting drugs, vaccines and diagnostics and new applications may require new …